Mycosis Fungoides Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials

Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
Conditions:   Cutaneous T Cell Lymphoma;   Mycosis Fungoides Interventions:   Drug: Mogamulizumab;   Drug: Brentuximab vedotin Sponsors:   University of Alabama at Birmingham;   Seagen Inc.;   Kyowa Kirin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials